Alamar Biosciences Inc IPO unlock schedule & public float
Lock-up schedule, public float and locked shares extracted from Alamar Biosciences Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Shares eligible to trade · by holder groupApr 17, 2026 → Oct 14, 2026 · 100% unlocked
Lock-up holders55.27M
IPO public float11.25M
About Alamar Biosciences Inc
Alamar Biosciences Inc is a life-sciences tools company developing precision proteomics technology for biomarker discovery and disease research.
What the company does
Develops immunoassay and proteomics platforms intended to detect and analyze low-abundance proteins.
Serves researchers, biopharma companies, and clinical-development teams that need sensitive biological measurement tools.
Competes on assay sensitivity, throughput, workflow reliability, data quality, and adoption by research and translational-medicine customers.
Business profile
Alamar Biosciences sits in the life-sciences tools market, where platform performance, installed-base growth, consumables pull-through, and research-budget demand shape the business.
SEC IPO filings
Effective
EDGAR filings resolved from ALMR / CIK 0002104204.